• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基孔肯雅森林病病毒:流行病学见解、发病机制、治疗策略以及疫苗与诊断技术的进展

Kyasanur Forest Disease Virus: Epidemiological Insights, Pathogenesis, Therapeutic Strategies, and Advances in Vaccines and Diagnostics.

作者信息

Bohra Babita, Srivastava Kumar Saurabh, Raj Ayush, Pal Nabanita, Shukla Rahul

机构信息

Division of Virus Research and Therapeutics, CSIR-Central Drug Research Institute, Lucknow 226031, India.

Academy of Scientific and Innovative Research, Ghaziabad 201002, India.

出版信息

Viruses. 2025 Jul 22;17(8):1022. doi: 10.3390/v17081022.

DOI:10.3390/v17081022
PMID:40872737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12390728/
Abstract

Kyasanur Forest disease virus (KFDV), a tick-borne Orthoflavivirus endemic to the Indian subcontinent, is a public health threat due to its recurrent outbreaks and expanding geographic range. This review provides a comprehensive overview of KFDV, encompassing its epidemiological trends, transmission dynamics, and ecological determinants that influence its spread. We delve into the current understanding of KFDV pathogenesis, highlighting key viral and host factors that drive infection and disease progression. Despite the absence of targeted antiviral therapies, recent advances have spurred the development of candidate therapeutics, including broad-spectrum antivirals and immunomodulators. We also discuss progress in vaccine development, with an emphasis on the limitations of the existing formalin-inactivated vaccine and the promise of next-generation platforms. Furthermore, we explore recent innovations in diagnostics, including molecular and serological tools, that aim to improve early detection and surveillance. A multidisciplinary approach integrating virology, immunology, ecology, and public health is essential for the effective management and eventual control of KFDV outbreaks.

摘要

基孔肯雅森林病病毒(KFDV)是一种蜱传正黄病毒,在印度次大陆流行,由于其反复爆发和地理范围不断扩大,对公共卫生构成威胁。本综述全面概述了KFDV,包括其流行病学趋势、传播动态以及影响其传播的生态决定因素。我们深入探讨了目前对KFDV发病机制的理解,强调了驱动感染和疾病进展的关键病毒和宿主因素。尽管缺乏靶向抗病毒疗法,但最近的进展推动了候选疗法的开发,包括广谱抗病毒药物和免疫调节剂。我们还讨论了疫苗开发的进展,重点介绍了现有福尔马林灭活疫苗的局限性以及下一代平台的前景。此外,我们探索了诊断方面的最新创新,包括分子和血清学工具,旨在改善早期检测和监测。整合病毒学、免疫学、生态学和公共卫生的多学科方法对于有效管理和最终控制KFDV疫情至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/1f7a8e9fa0c7/viruses-17-01022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/793aa4fdcf3f/viruses-17-01022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/4d9f2b3921fb/viruses-17-01022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/1f7a8e9fa0c7/viruses-17-01022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/793aa4fdcf3f/viruses-17-01022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/4d9f2b3921fb/viruses-17-01022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9eec/12390728/1f7a8e9fa0c7/viruses-17-01022-g003.jpg

相似文献

1
Kyasanur Forest Disease Virus: Epidemiological Insights, Pathogenesis, Therapeutic Strategies, and Advances in Vaccines and Diagnostics.基孔肯雅森林病病毒:流行病学见解、发病机制、治疗策略以及疫苗与诊断技术的进展
Viruses. 2025 Jul 22;17(8):1022. doi: 10.3390/v17081022.
2
Epidemiology, Pathogenesis, and Control of a Tick-Borne Disease- Kyasanur Forest Disease: Current Status and Future Directions.蜱传疾病-基孔肯雅热的流行病学、发病机制和控制:现状与未来方向。
Front Cell Infect Microbiol. 2018 May 9;8:149. doi: 10.3389/fcimb.2018.00149. eCollection 2018.
3
Exploration of effective pharmacological inhibitors for NS5 protein through computational approach: A strategy to combat the neglected Kyasanur forest disease virus.通过计算方法探索NS5蛋白的有效药理抑制剂:对抗被忽视的基孔肯雅森林病病毒的策略
PLoS One. 2025 Jul 10;20(7):e0325613. doi: 10.1371/journal.pone.0325613. eCollection 2025.
4
Schmallenberg virus epidemiology and regional control strategies: diagnostics, vaccines, and vector management.施马伦贝格病毒流行病学与区域防控策略:诊断、疫苗及病媒管理
Front Cell Infect Microbiol. 2025 Jul 14;15:1633030. doi: 10.3389/fcimb.2025.1633030. eCollection 2025.
5
Purification and characterization of kyasanur forest disease virus EDIII domain of major envelope glycoprotein.基孔肯雅森林病病毒主要包膜糖蛋白的E结构域Ⅲ的纯化与鉴定
J Virol Methods. 2025 Apr;333:115089. doi: 10.1016/j.jviromet.2024.115089. Epub 2024 Dec 3.
6
Kyasanur Forest Disease in India: innovative options for intervention.印度基孔肯雅热:干预的创新选择。
Hum Vaccin Immunother. 2019;15(10):2243-2248. doi: 10.1080/21645515.2019.1602431. Epub 2019 May 7.
7
Kyasanur forest disease: an epidemiological view in India.基孔肯雅森林病:印度的流行病学视角
Rev Med Virol. 2006 May-Jun;16(3):151-65. doi: 10.1002/rmv.495.
8
Kyasanur Forest Disease (KFD): Rare Disease of Zoonotic Origin.基孔肯雅热森林病(KFD):一种罕见的人畜共患病源性疾病。
J Nepal Health Res Counc. 2016 Sep;14(34):214-218.
9
A preliminary ecological profile of Kyasanur Forest disease virus hosts among the mammalian wildlife of the Western Ghats, India.印度西高止山脉哺乳动物野生动物中基孔肯雅热病毒宿主的初步生态特征描述。
Ticks Tick Borne Dis. 2020 Jul;11(4):101419. doi: 10.1016/j.ttbdis.2020.101419. Epub 2020 Mar 23.
10
Characterization of host receptor interaction with envelop protein of Kyasanur forest disease virus and predicting suitable epitopes for vaccine candidate.宿主受体与基孔肯雅森林病病毒包膜蛋白相互作用的表征及候选疫苗合适表位的预测。
J Biomol Struct Dyn. 2024 May;42(8):4110-4120. doi: 10.1080/07391102.2023.2218924. Epub 2023 Jun 5.

本文引用的文献

1
Molecular epidemiology of Kyasanur forest disease employing ONT-NGS a field forward sequencing.采用ONT-NGS现场正向测序的基桑努尔森林病分子流行病学
J Clin Virol. 2025 Apr;177:105783. doi: 10.1016/j.jcv.2025.105783. Epub 2025 Mar 28.
2
Construction of an immunoinformatics-based multi-epitope vaccine candidate targeting Kyasanur forest disease virus.基于免疫信息学构建靶向卡萨努尔森林病病毒的多表位疫苗候选物。
PeerJ. 2025 Mar 21;13:e18982. doi: 10.7717/peerj.18982. eCollection 2025.
3
Purification and characterization of kyasanur forest disease virus EDIII domain of major envelope glycoprotein.
基孔肯雅森林病病毒主要包膜糖蛋白的E结构域Ⅲ的纯化与鉴定
J Virol Methods. 2025 Apr;333:115089. doi: 10.1016/j.jviromet.2024.115089. Epub 2024 Dec 3.
4
Kyasanur Forest Disease: An Epidemiological Investigation and Case-Control Study in Shivamogga, Karnataka, India-2022.基孔肯雅热:印度卡纳塔克邦希瓦莫加的一项流行病学调查和病例对照研究-2022 年。
Int J Public Health. 2024 Oct 18;69:1606715. doi: 10.3389/ijph.2024.1606715. eCollection 2024.
5
Kyasanur Forest Disease: A Comprehensive Review.基孔肯雅森林病:全面综述
Cureus. 2024 Jul 23;16(7):e65228. doi: 10.7759/cureus.65228. eCollection 2024 Jul.
6
Sociodemographic factors associated with Kyasanur forest disease in India - a retrospective study.印度与基孔肯雅森林病相关的社会人口学因素——一项回顾性研究
IJID Reg. 2024 Feb 15;10:219-227. doi: 10.1016/j.ijregi.2024.02.002. eCollection 2024 Mar.
7
An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia.一项在澳大利亚健康成年人中进行的观察者盲法、随机、安慰剂对照、1 期、单次递增剂量的登革单抗研究。
Lancet Infect Dis. 2024 Jun;24(6):639-649. doi: 10.1016/S1473-3099(24)00030-6. Epub 2024 Feb 23.
8
Live, Attenuated, Tetravalent Butantan-Dengue Vaccine in Children and Adults.儿童和成人中使用减毒活、四价 Butantan-登革热疫苗。
N Engl J Med. 2024 Feb 1;390(5):397-408. doi: 10.1056/NEJMoa2301790.
9
Kyasanur Forest disease virus NS3 helicase: Insights into structure, activity, and inhibitors.基孔肯雅热病毒 NS3 解旋酶:结构、活性与抑制剂研究进展。
Int J Biol Macromol. 2024 Jan;254(Pt 3):127856. doi: 10.1016/j.ijbiomac.2023.127856. Epub 2023 Nov 2.
10
Single-dose VSV-based vaccine protects against Kyasanur Forest disease in nonhuman primates.单次剂量基于水疱性口炎病毒的疫苗可预防非人灵长类动物感染基孔肯雅热。
Sci Adv. 2023 Sep 8;9(36):eadj1428. doi: 10.1126/sciadv.adj1428. Epub 2023 Sep 6.